AK Medical to Convene 26 Aug 2026 Board Meeting for H1 Results and Interim Dividend Review

Bulletin Express

08/14

AK Medical Holdings Limited (AK Medical) has scheduled a board meeting for 26 August 2026 at the Group’s Global Operation Center in Beijing. The agenda includes consideration and approval of the consolidated interim results for the six months ended 30 June 2026 and deliberation on the declaration of an interim dividend.

The meeting will be chaired by Chairman Li Zhijiang and attended by the full Board, comprising four executive Directors (Li Zhijiang, Zhang Bin, Zhang Chaoyang, Zhao Xiaohong), one non-executive Director (Dr. Wang David Guowei) and three independent non-executive Directors (Kong Chi Mo, Dr. Li Shu Wing David, Dr. Gao Wei).

The company’s announcement, released on 14 August 2026, emphasizes that any interim dividend decision will be contingent upon the Board’s review of the half-year financial performance.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1184965148"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1184965148\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1184965148?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-14 08:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184965148","market":"us","top_or_hot":-1,"title":"AK Medical to Convene 26 Aug 2026 Board Meeting for H1 Results and Interim Dividend Review","media":"Bulletin Express","content":"<p>AK Medical Holdings Limited (AK Medical) has scheduled a board meeting for 26 August 2026 at the Group’s Global Operation Center in Beijing. The agenda includes consideration and approval of the consolidated interim results for the six months ended 30 June 2026 and deliberation on the declaration of an interim dividend.</p>\n<p>The meeting will be chaired by Chairman Li Zhijiang and attended by the full Board, comprising four executive Directors (Li Zhijiang, Zhang Bin, Zhang Chaoyang, Zhao Xiaohong), one non-executive Director (Dr. Wang David Guowei) and three independent non-executive Directors (Kong Chi Mo, Dr. Li Shu Wing David, Dr. Gao Wei).</p>\n<p>The company’s announcement, released on 14 August 2026, emphasizes that any interim dividend decision will be contingent upon the Board’s review of the half-year financial performance.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AK Medical to Convene 26 Aug 2026 Board Meeting for H1 Results and Interim Dividend Review</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAK Medical to Convene 26 Aug 2026 Board Meeting for H1 Results and Interim Dividend Review\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-14 08:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>AK Medical Holdings Limited (AK Medical) has scheduled a board meeting for 26 August 2026 at the Group’s Global Operation Center in Beijing. The agenda includes consideration and approval of the consolidated interim results for the six months ended 30 June 2026 and deliberation on the declaration of an interim dividend.</p>\n<p>The meeting will be chaired by Chairman Li Zhijiang and attended by the full Board, comprising four executive Directors (Li Zhijiang, Zhang Bin, Zhang Chaoyang, Zhao Xiaohong), one non-executive Director (Dr. Wang David Guowei) and three independent non-executive Directors (Kong Chi Mo, Dr. Li Shu Wing David, Dr. Gao Wei).</p>\n<p>The company’s announcement, released on 14 August 2026, emphasizes that any interim dividend decision will be contingent upon the Board’s review of the half-year financial performance.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01789","symbol_name":"爱康医疗","start_time":0,"source_url":"","article_id":"1184965148","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184965148","pubTimestamp":1786665954,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"AK Medical Holdings Limited (AK Medical) has scheduled a board meeting for 26 August 2026 at the Group’s Global Operation Center in Beijing. The agenda includes consideration and approval of the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01789":"爱康医疗"},"translate_title":"AK Medical 将于 2026 年 8 月 26 日召开董事会会议，审查上半年业绩和中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01789":1},"content_text":"AK Medical Holdings Limited (AK Medical) has scheduled a board meeting for 26 August 2026 at the Group’s Global Operation Center in Beijing. The agenda includes consideration and approval of the consolidated interim results for the six months ended 30 June 2026 and deliberation on the declaration of an interim dividend.\nThe meeting will be chaired by Chairman Li Zhijiang and attended by the full Board, comprising four executive Directors (Li Zhijiang, Zhang Bin, Zhang Chaoyang, Zhao Xiaohong), one non-executive Director (Dr. Wang David Guowei) and three independent non-executive Directors (Kong Chi Mo, Dr. Li Shu Wing David, Dr. Gao Wei).\nThe company’s announcement, released on 14 August 2026, emphasizes that any interim dividend decision will be contingent upon the Board’s review of the half-year financial performance.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}